Current stock page

Catalysts

CLOV Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Healthcare PlansScore data as of Sep 4, 2026

CLOV

Catalysts
Clover Health Investments, Corp.
Healthcare· Medical - Healthcare Plans
AIQ Score
NeutralAIQ Edge 2/10
Low Priority
Relative Laggard
Score data as of Sep 4, 2026
Last price
$4.26
+$0.00 (+0.00%)
Latest market quote
Momentum47
Value42
Quality38
Risk Resilience37
Sentiment
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Nov 4, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 41/100

Momentum 47/100 and sentiment before the next covered event.

Recent coverage
5 articles

Updated Sep 6, 2026 · Sentiment 5.15%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 47/100AIQ Edge 2/10 Relative Laggard
Beat rate
50%
4 of 8 reported periods
Average surprise
-27.7%
Across covered historical reports
Latest result
+29.4%
Aug 5, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Aug 5, 2026$0.04$0.05+29.4%$728.27M$743.17M
May 6, 2026$0.07$0.07+0.0%$714.89M$749.19M
Feb 26, 2026-$0.10-$0.05+51.0%$467.06M$487.71M
Nov 4, 2025$0.02-$0.05-350.0%$467.06M$496.65M
Aug 5, 2025-$0.01-$0.02-116.7%$468.3M$477.62M
May 6, 2025-$0.07$0.05+171.4%$466.93M$462.33M
Feb 27, 2025-$0.07-$0.04+42.9%$347.41M$336.96M
Nov 6, 2024-$0.01-$0.02-50.0%$348.02M$330.99M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
1
Buy
2
Hold
12-month analyst target
$4.86
+14.22% versus current price
Based on 2 analyst observations. Targets are estimates, not predictions.
Low target
$4.20
-1.29% vs latest price
Average target
$4.86
+14.22% vs latest price
High target
$5.50
+29.26% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateNov 4, 2026

Next known earnings or reporting date.

EPS estimate-$0.00

Current analyst expectation for the upcoming report.

Revenue estimate$738.18M

Current analyst expectation for the upcoming report.

Sentiment score

News pressure around the setup.

Momentum score47

Where event reaction would show up first.

AIQ score41/100

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
2
Average target
$4.86
Target upside
14.22%
Target range
$4.20 - $5.50
90-day revisions
41

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
2
Neutral
2
Negative
1
insidermonkey.com · Sep 3, 2026

Clover Health (CLOV) Turns Profitable As Medicare Membership Explodes

On August 5, Clover Health Investments Corp. (NASDAQ:CLOV) reported second-quarter 2026 results that turned a year-ago loss into real profit.

manilatimes.net · Aug 31, 2026

Clover Health to Participate in Upcoming Investor Conferences

WILMINGTON, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ('Clover,” 'Clover Health” or the 'Company”), today announced its participation in the following investor conferences:

seekingalpha.com · Aug 26, 2026

Clover Health Is A 'Buy' Because Of Its AI (NASDAQ:CLOV)

Clover Health Investments leverages its AI-powered Clover Assistant to drive lower claims costs and improve member profitability. Click for more on CLOV stock.

seekingalpha.com · Aug 19, 2026

Clover Health's High Valuation Ignores Low-Margin Structural Realities (NASDAQ:CLOV)

Clover Health's current valuation ignores cash flow limits, MLR risk, CMS bonus uncertainty, and challenging software business. See why I rate CLOV stock a Sell.

seekingalpha.com · Aug 15, 2026

Clover Health Investments: Real Turnaround, But Already Priced In (NASDAQ:CLOV)

Clover Health gets a Hold rating from a strong Medicare Advantage growth, but valuation and CMS litigation risks cap upside. Click here to read more on CLOV.

Open full news and sentiment

CLOV Catalysts FAQ

What are the next catalysts for CLOV stock?

CLOV's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move CLOV stock?

Upcoming events that could move CLOV include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could CLOV's next earnings report affect the stock?

CLOV's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive CLOV stock higher?

CLOV could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt CLOV stock?

CLOV could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.